Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Journal of the International AIDS Society|August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East AfricaYifan Li, Bethany L Dearlove, Eric Lewitus, et al.
JCI Insight|July 11, 2023
Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisitionAlexandra Schuetz, Michael J Corley, Carlo Sacdalan, et al.
The Journal of Clinical Investigation|May 8, 2025
NK cell activation and CD4 T cell α4β7 expression are associated with susceptibility to HIV-1Kawthar Machmach, Kombo F N'guessan, Rohit Farmer, et al.
AIDS (London, England)|February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infectionJacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
The Journal of Infectious Diseases|March 11, 2022
Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of InfectionEugène Kroon, Suthat Chottanapund, Supranee Buranapraditkun, et al.
Psychosomatic Medicine|September 26, 2022
Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV InfectionRobert Paul, Kyu Cho, Jacob Bolzenius, et al.
Journal of Clinical Microbiology|December 17, 2025
HIV serologic reactivity varies with time of ART initiation in persons on long-term ARTVivian I Avelino-Silva, Mars Stone, Clara Di Germanio, et al.
Journal of Clinical Microbiology|June 4, 2025
Improved HIV-1 RNA detection using whole blood versus plasma in antiretroviral-treated individualsVivian I Avelino-Silva, Mars Stone, Leilani Montalvo, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Pageof 13